Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

3.55
BATS BZX Real-Time Price
As of 12:09pm ET
 +0.09 / +2.60%
Today’s Change
1.63
Today|||52-Week Range
15.96
-65.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line-39.1M-30.1M-45.2M-43.0M
 
 
 
 
 
Depreciation628.0K304.0K177.0K180.0K
 
 
 
 
 
Total Other Cash Flow5.4M-534.0K5.2M10.7M
 
 
 
 
 
Funds From Operations-33.1M-30.3M-39.9M-32.1M
 
 
 
 
 
Funds From/For Other Operating Expenses4.3M-3.8M-1.3M-19.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-37.4M-26.5M-38.6M-13.1M
 
 
 
 
 
 
InvestingIncrease In Investments-16.2M-24.0M-73.9M-53.8M
 
 
 
 
 
Decrease In Investments40.8M20.3M34.0M42.4M
 
 
 
 
 
Capital Expenditures-113.0K-30.0K-106.0K-5.1M
 
 
 
 
 
Fixed Asset Disposal--50.0K0.000.00
 
 
Other Investing - Sources317.0K157.0K1.0K0.00
 
 
 
 
Net Cash Flow Investing24.9M-3.5M-40.0M-16.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale18.7M25.1M111.9M5.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.005.2M0.000.00
 
 
Other Uses - Financing1.7M0.000.000.00
 
 
Net Cash Flow - Financing17.0M30.3M111.9M5.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.00----
 
Net Change In Cash4.4M273.0K33.4M-24.2M